The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

Cell

Volumn 85, Issue 7, 1996, Pages 1135-1148

  Choe, Hyeryun ^a   Farzan, Michael ^a   Sun, Ying ^a   Sullivan, Nancy ^a,b   Rollins, Barrett ^a   Ponath, Paul D ^c   Wu, Lijun ^c   Mackay, Charles R ^c   LaRosa, Gregory ^c   Newman, Walter ^c   Gerard, Norma ^d   Gerard, Craig ^d   Sodroski, Joseph ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; GLYCOPROTEIN GP 120; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; RECEPTOR;

ANIMAL CELL; CELL FUSION; CONTROLLED STUDY; DOG; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNCYTIUM;

ANIMALIA; CANIS FAMILIARIS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0005014748     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81313-6     Document Type: Article

References (109)

1. Alizon, M., Wain-Hobson, S., Montagnier, L., and Sonigo, P. (1986). Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell 46, 63-74.
2. Ashorn, P., Berger, E., and Moss. J. (1990). Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64, 2149-2156.
3. Åsjö, B., Mörfeldt-Manson, L., Albert, L.J., Biberfeld, G., Karlson, A., Lidman, K., and Fenyö, M. (1986). Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2, 660-662.
4. Baggiolini, M., DeWold, B., and Moser, B. (1994). Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55, 97-179.
5. 2-adrenergic receptor sequestration. J. Biol. Chem. 269, 2790-2795.
6. Barré-Sinoussi, F., Chermann, J.C., Rey, F., Nugéyre, M.T., Chamaret, S., Gruest, J., Dauget, C., Axler-Bin, C., Vezinet-Brun, F., Rouzioux, C., et al. (1983). Isolation of a T-lymphocyte retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220, 868-871.
7. Bergeron, L., Sullivan, N., and Sodroski, J. (1992). Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J. Virol. 66, 2389-2397.
8. Birkenbach, M., Josefsen, K., Yalamanchili, R., Lenoir, G., and Kieff, E. (1993). Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67, 2209-2220.
9. Bou-Habib, D., Rodriguez, G., Oravecz, T., Berman, P., Lusso, P., and Norcross, M. (1994). Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68, 6006-6013.
10. Brand, D., Srinivasan, K., and Sodroski, J. (1995). Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein. J. Virol. 69, 166-171.
11. Broder, C., Dimitrov, D., Blumenthal, R., and Berger, E. (1993). The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 193, 483-491.
12. + T cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA 92, 9004-9008.
13. Burton, D., Pyati, J., Koduri, R., Sharp, S., Thornton, G., Parren, P., Sawyer, L., Hendry, R., Dunlop, N., Nara, P., et al. (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
14. Carrillo, A., Trowbridge, D., Westervelt, P., and Ratner, L (1993). Identification of HIV-1 determinants for T lymphoid cell line infection. Virology 197, 817-824.
15. Charo, I., Myers, S., Herman, F., Franci, C., Connolly, A., and Coughlin, S. (1994). Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91, 2752-2756.
16. Chaudhuri, A., Polyakova, J., Zbrzezna, V., Williams, K., Gulatis, X., Pogo, A.O. (1993). Cloning of gpD protein cDNA, the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc. Natl. Acad. Sci. USA 29, 10793-10797.
17. Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J.A. (1988). Biologic features of HIV-1 that correlate with virulence in the host. Science 240, 80-82.
18. Cheng-Mayer, C., Quiroga, M., Tung, J.W., Dina, D., and Levy, J.A. (1990). Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol. 64, 4390-4398.
19. Chesebro, B., Buller, R., Protis, J., and Wehrly, K. (1990). Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J. Virol. 64, 215-221.
20. Chesebro, B., Nishio, J., Perryman, S., Cann, A., O'Brien, W., Chen, I., and Wehrly, K. (1991). Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J. Virol. 65, 5782-5789.
21. Chesebro, B., Wehrly, K., Nishio, J., and Perryman, S. (1992). Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66, 6547-6554.
22. Clapham, P.R., Blanc, D., and Weiss, R. (1991). Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181, 703-715.
23. + T cells. Science 270, 1811-1815.
24. Collman, R., Balliet, J., Gregory, S., Friedman, H., Kolson, D., Nathanson, N., and Srinivasan, A. (1992). An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66, 7517-7521.
25. Connor, R.I., and Ho, D.D. (1994a). Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68, 4400-4408.
26. Connor, R.I., and Ho, D.D. (1994b). Transmission and pathogenesis of human immunodeficiency virus type 1. AIDS Res. Hum. Retro. 10, 321-323.
27. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67, 1772-1777.
28. Cullen, B.R. (1989). Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152, 64-73.
29. Cundell, D., Gerard, N., Gerard, G., Idanpaan-Heikkila, I., and Tuomanen, E. (1995). Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377, 435-438.
30. Dalgleish, A.G., Beverly, P.C.L., Clapham, P.R., Crawford, D.H., Greaves, M.F., and Weiss, R.A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
31. Daugherty, B., Siciliano, S., DeMartino, J., Malkowitz, L., Sirotina, A., and Springer, M. (1996). Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183, 2349-2354.
32. Dragic, T., Charneau, P., Clavel, F., and Alizon, M. (1992). Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J. Virol. 66, 4794-4802.
33. Fauci, A., Macher, A., Longo, D., Lane, H.C., Rook, A., Masur, H., and Gelmann, E. (1984). Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann. Int. Med. 100, 92-106.
34. Federsppiel, B., Melhado, I., Duncan, A., Delaney, A., Schappert, K., Clark-Lewis, I., and Jirik, F. (1993). Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 16, 707-712.
35. Feng, Y., Broder, C., Kennedy, P., and Berger, E. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
36. Fenyö, E., Morfeldt-Manson, L., Chiodi, F., Lind, B., Von Gegerfelt, A., Albert, J., Olausson, E., and Åsjö, B. (1988). Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62, 4414-4419.
37. Fisher, A., Collalti, E., Ratner, L., Gallo, R., and Wong-Staal, F. (1985). A molecular clone of HTLV-III with biologic activity. Nature 316, 262-265.
38. Freed, E., Myers, D., and Risser, R. (1991). Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J. Virol. 65, 190-194.
39. Freedman, A., Gibson, F., Fleming, S., Spry, C., and Griffin, G. (1991). Human immunodeficiency virus infection of eosinophils in human bone marrow cultures. J. Exp. Med. 174, 1661-1664.
40. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., et al. (1984). Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
41. Gao, F., Morrison, S., Robertson, D., Thornton, C., Craig, S., Karlsson, G., Sodroski, J., Morgado, M., Galvao-Castro, B., von Briesen, H., et al. and the WHO and NIAID Networks for HIV Isolation and Characterization. (1996). Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J. Virol. 70, 1651-1667.
42. Gartner, S., Markovits, P., Markovitz, D., Kaplan, M., Gallo, R., and Popovic, M. (1986). The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219.
43. Gendelman, H., Orenstein, J., Martin, M., Ferrva, C., Mitra, R., Phipps, T., Wahl, L., Lane, C., Fauci, A., and Burke, D. (1988). Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167, 1428-1441.
44. Gerard, N., and Gerard, C. (1994). The pro-inflammatory seven-transmembrane-segment receptors of the leukocyte. Curr. Opin. Immunol. 6, 140-145.
45. Goudsmit, J., Debouck, C., Meloen, R., Smit, L., Bakker, M., Asher, D., Wolff, A., Gibbs, C., and Gajdusek, D. (1988). Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85, 4478-4482.
46. Grimaila, R., Fuller, B., Rennert, P., Nelson, M., Hammarksjöld, M.-L., Potts, B., Murray, M., Putney, S., and Gray, G. (1992). Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization. J. Virol. 66, 1875-1883.
47. Helseth, E., Kowalski, M., Gabuzda, D., Olshevsky, U., Haseltine, W., and Sodroski, J. (1990). Rapid complementation assays measuring replicative potential of HIV-1 envelope glycoprotein mutants. J. Virol. 64, 2416-2420.
48. Horuk, R., Chitnis, C., Darbonne, W., Colby, T., Rybicki, A., Hadley, T., and Miller, L. (1993). The erythrocyte chemokine receptor is a receptor for the malarial parasite Plasmodium vivax. Science 261, 1182-1184.
49. Horuk, R. (1994). Molecular properties of the chemokine receptor family. Trends Pharmacol. Sci. 15, 159-165.
50. Hwang, S., Boyle, T., Lyerly, H., and Cullen, B. (1991). Identification of the V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74.
51. Ivanoff, L., Looney, D., McDanal, C., Morris, J., Wong-Staal, F., Langlois, A., Petteway, S., and Matthews, T. (1991). Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. AIDS Res. Hum. Retroviruses 7, 595-603.
52. Javaherian, K., Langlois, A., McDanal, C., Ross, I.K., Eckler, L., Jellis, C., Profy, A., Rusche, J., Bolognesi, D., Putney, S., and Matthews, T. (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86, 6768-6772.
53. Jazin, E., Yoo, H., Blomqvist, A., Yee, F., Weng, G., Walber, M., Salon, J., Larhammar, D., and Wahlestedt, C. (1993). A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells. Regulatory Peptides 47, 247-258.
54. Jose, P.J., Griffiths-Johnson, D.A., Collins, P.D., Walsh, D.T., Moqbel, R., Totty, N.F., Truong, O., Hsuan, J.J., and Williams, T.J. (1994). Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179, 881-887.
55. Karlsson, G., Gao, F., Robinson, J., Hahn, B., and Sodroski, J. (1996). Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses. J. Virol., in press.
56. Kitaura, M., Nakajima, T., Imai, T., Harado, S., Combadiere, C., Tiffany, H.L., Murphy, P., and Yoshie, O. (1996). Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271, 7725-7730.
57. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.C., and Montagnier, L (1984). T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 312, 767-768.
58. Koenig, S., Gendelman, H., Orenstein, J., DalCanto, M., Pezeshkpour, G., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M., and Fauci, A. (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089-1092.
59. Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W.G., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., and Sodroski, J. (1987). Functional regions of the human immunodeficiency virus envelope glycoproteins. Science 237, 1351-1355.
60. Kunz, D., Gerard, N.P., and Gerard, C. (1991). The human leukocyte platelet activating factor receptor. J. Biol. Chem. 267, 9101-9106.
61. Landau, N.R., Page, K.A., and Littman, D.R. (1991). Pseudotyping with human T-cell leukemia virus type 1 broadens the human immunodeficiency virus host range. J. Virol. 65, 162-169.
62. Leonard, C., Spellman, M., Riddle, L., Harris, R., Thomas, J., and Gregory, T. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265, 10373-10382.
63. Li, Y., Kappas, J.C., Conway, J.A., Price, R.W., Shaw, G.M., and Hahn, B.H. (1991). Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent-defective viral genomes. J. Virol. 65, 3973-3985.
64. Lifson, J., Feinberg, M., Reyes, G., Rabin, L., Banapour, B., Chakrabarti, S., Moss, B., Wong-Staal, F., Steimer, K., and Engleman, E. (1986). Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Science 323, 725-728.
65. Linsley, P., Ledbetter, J., Thomas, E., and Hu, S.-L. (1988). Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. J. Virol. 62, 3695-3702.
66. Loetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M., and Moser, B. (1994). Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269, 232-237.
67. Maddon, P., Dalgleish, A., McDougal, J.S., Clapham, P., Weiss, R., and Axel, R. (1986). The T4 gene encodes the AIDS receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
68. Mascola, J., Louwagie, J., McCutchan, F., Fischer, C., Hegerich, P., Wagner, K., Fowler, A., McNeil, J., and Burke, D. (1994). Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169, 48-54.
69. + T cells by a complex of the 100K viral protein and the T4 molecule. Science 231, 382-385.
70. McKnight, A., Clapham, P.R., and Weiss, R.A. (1994). HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology 201, 8-18.
71. Montefiori, D., Zhou, J., Barnes, B., Lake, D., Hersh, E., Masuho, Y., and Lefkowitz, L. (1991). Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus. Virology 182, 635-643.
72. Moore, J., Sattentau, Q., Wyatt, R., and Sodroski, J. (1994). Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68, 469-484.
73. Moore, J.P., Cao, Y., Qiing, L., Sattentau, Q.J., Pyati, J., Koduri, R., Robinson, J., Barbas III, C.F., Burton, D., and Ho, D.D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69, 101-109.
74. Myers, G., Wain-Hobson, S., Henderson, L., Korber, B., Jeang, K.-T., and Pavlakis, G. (1994). Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Los Alamos, New Mexico: Los Alamos National Laboratory).
75. Neote, K., DiGregorio, D., Mak, J., Horuk, R., and Schall, T. (1993). Molecular cloning, functional expression, and signalling characteristics of a C-C chemokine receptor. Cell 72, 415-425.
76. O'Brien, W., Koyanagi, Y., Namazie, A., Zho, J.-Q., Diagne, A., Idler, K., Zack, J., and Chen, I.S.Y. (1990). HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature (London) 348, 69-73.
77. Page, K., Stearns, S., and Littman, D. (1992). Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J. Virol. 66, 524-533.
78. Palermo, D.P., DeGraaf, M.E., Marotti, K.R., Rehberg, E., and Post, L.E. (1991). Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression. J. Biotech. 19, 35-47.
79. Paxton, W.A., Martin, S., Tse, D., O'Brien, T., Skurnick, J., Van Devanter, N., Padian, N., Braun, J., Kotler, D., Wolinsky, S., and Koup, R. (1996). Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2, 412-417.
80. Peden, K., Emerman, M., and Montagnier, L. (1991). Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology 185, 661-672.
81. Ponath, P., Qin, S., Ringler, D., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J.-A., Newman, W., et al. (1996a). Cloning of the human eosinophil chemoattractant, eotaxin: Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97, 604-612.
82. Ponath, P., Qin, S., Post, T., Wang, J., Wu, L., Gerard, N., Newman, W., Gerard, C., and Mackay, C. (1996b). Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183, 1-12.
83. Pope, M., Betjes, M., Romani, N., Hirmand, H., Cameron, P., Hoffman, L., Gezelter, S., Schuler, G., and Steinman, R. (1994). Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398.
84. Power, C., Myer, A., Nemeth, K., Bacon, K., Hoogewerf, A., Proudfoot, A., and Wells, T. (1995). Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 270, 19495-19500.
85. Probst, W., Snyder, L., Schuster, D., Brosius, J., and Sealfon, S. (1992). Sequence alignment of the G protein-coupled receptor superfamily. DNA Cell Biol. 11, 1-20.
86. Putney, S., Matthews, T., Robey, W.G., Lynn, D., Robert-Guroff, M., Mueller, W., Langlois, A., Ghrayeb, J., Petteway, S., Weinhold, K., et al. (1986). HTLV-III/LAV-neutralizing antibodies to the E. coli produced fragment of the virus envelope. Science 234, 1392-1395.
87. Raport, C., Gosling, J., Schweickart, V., Gray, P., and Charo, I. (1996). Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1β, and MIP-1α. J. Biol. Chem., in press.
88. Rusche, J., Javaherian, K., McDanal, C., Petro, J., Lynn, D., Grimaila, R., Langlois, A., Gallo, R., Arthur, L., Fischinger, P., et al. (1988). Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino-acid sequence of the viral envelope gp120. Proc. Natl. Acad. Sci. USA 85, 3198-3202.
89. Samson, M., Labbe, O., Mollereau, C., Vassart, G., and Parmentier, M. (1996). Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35, 3362-3367.
90. Schall, T.J., and Bacon, K.B. (1994). Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6, 865-873.
91. Schuitemaker, H., Kootstra, N., de Goede, R., de Wolf, F., Miedema, F., and Tersmette, M. (1991). Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable at all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65, 356-363.
92. Schuitemaker, H., Koot, M., Koostra, N.A., Dercksen, M.W., de Goede, R.E.Y., van Steenwijk, R.P., Lange, J.M.A., Eeftink-Schattenkerk, J.K.M., Miedema, F., and Tersmette, M. (1992). Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 65, 356-363.
93. Skinner, M., Langlois, A., McDanal, C., McDougal, J.S., Bolognesi, D., and Matthews, T. (1988). Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res. Hum. Retrovir. 4, 187-197.
94. Sodroski, J., Goh, W.C., Rosen, C.A., Campbell, K., and Haseltine, W. (1986). Role of the HTLV-III envelope in syncytium formation and cytopathicity. Nature 321, 412-417.
95. Sozzani, S., Sallusto, F., Luini, W., Zhou, D., Piemonti, L., Allavena, P., Van Dame, J., Valitutti, S., Lanzavecchia, A., and Mantovani, A. (1995). Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155, 3292-3295.
96. Spira, A., Marx, P., Patterson, B., Mahoney, J., Koup, B., Wolinsky, S., and Ho, D.D. (1996). Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215-225.
97. Stein, B., Gouda, S., Lifson, J., Penhallow, R., Bensch, K., and Engleman, E. (1987). pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49, 659-668.
98. Sullivan, N., Sun, Y., Li, J., Hoffman, W., and Sodroski, J. (1995) Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69, 4413-4422.
99. Tersmette, M., de Goede, R.E.Y., Al, B.J.M., Winkel, I.N., Gruters, R.A., Cuypers, H.T., Huisman, H.G., and Miedema, F. (1988). Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62, 2026-2032.
100. Thali, M., Bukovsky, A., Kondo, E., Rosenwirth, B., Walsh, C., Sodroski, J., and Göttlinger, H. (1994). Functional association of cyclophilin A with HIV-1 virions. Nature 372, 363-365.
101. + cells. Virology 186, 313-317.
102. Valentin, A., Albert, J., Fenyö, E., and Åsjö, B. (1994). Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68, 6684-6689.
103. von Zastrow, M., and Kobilka, B. (1992). Ligand-regulated internalization and recycling of human β2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J. Biol. Chem. 267, 3530-3538.
104. Weissman, D., Li, Y., Ananworanich, J., Zhou, L.-J., Adelsberger, J., Tedder, T., Baseler, M., and Fauci, A. (1995). Three populations of cells with dendritic morphology exist in peripheral blood only one of which is infectible with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 826-830.
105. Weller, P., Marshall, W., Lucey, D., Rand, T., Dvorak, A., and Finberg, R. (1995). Infection, apoptosis and killing of mature human eosinophils by human immunodeficiency virus-1. Am. J. Respir. Cell Mol. Biol. 10, 610-620.
106. Westervelt, P., Gendelman, H.E., and Ratner, L. (1991). Identification of a determinant within the human immunodeficiency virus surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88, 3097-3101.
107. Westervelt, P., Trowbridge, D., Epstein, L., Blumberg, B., Li, Y., Hahn, B., Shaw, G., Price, R., and Ratner, L. (1992). Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66, 2577-2582.
108. Willey, R.L., Theodore, T.S., and Martin, M.A. (1994). Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 68, 4409-4419.
109. Wrin, T., Loh, T., Vennari, J., Schuitemaker, H., and Nunberg, J. (1995). Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. J. Virol. 69, 39-48.